Stockscreener 앱 받기
23.68
2.38%
0.55
전일 마감가:
$23.13
열려 있는:
$23.51
하루 거래량:
3.63M
Relative Volume:
0.72
시가총액:
$11.83B
수익:
$4.72B
순이익/손실:
$-232.00M
주가수익비율:
-50.78
EPS:
-0.4663
순현금흐름:
$284.00M
1주 성능:
+2.38%
1개월 성능:
-5.96%
6개월 성능:
+10.55%
1년 성능:
+180.57%
1일 변동 폭
$23.25
$24.05
1주일 범위
$22.87
$24.43
52주 변동 폭
$8.33
$27.72
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.68 | 11.83B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
17.82 | 56.30B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
122.38 | 51.46B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.75 | 43.42B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 37.73B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
588.38 | 25.79B | 3.18B | 1.33B | 1.04B | 27.90 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Elanco Animal Health (NYSE:ELAN) Downgraded by Wall Street Zen to Buy - MarketBeat
174,412 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Elanco Animal Health Price Target Announced at $30.00/Share by Citigroup - Moomoo
Citi Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement - ChartMill
Elanco Animal Health Inc (ELAN) Shares Fall 3.6% -- GF Value Says Still Overvalued - GuruFocus
ELAN Initiated Coverage by Citigroup -- Price Target Announced a - GuruFocus
Citi Initiates Elanco Animal Health(ELAN.US) With Buy Rating, Announces Target Price $30 - Moomoo
Is Elanco (ELAN) Using Mass-Market Collars to Quietly Redefine Its Companion Animal Strategy? - Yahoo Finance
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its 1-Year Share Price Surge? - Yahoo Finance
Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More - Yahoo Finance
Citigroup Begins Coverage on Elanco Animal Health (NYSE:ELAN) - MarketBeat
Elanco Animal Health: Leading With Innovation, Impact, and Purpose - marketscreener.com
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Up 49.0% in March - MarketBeat
630,840 Shares in Elanco Animal Health Incorporated $ELAN Acquired by Hardman Johnston Global Advisors LLC - MarketBeat
Elanco Animal Health Inc Investor Day Transcript - GuruFocus
Q3 2025 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Institution Moves: Is Elanco Animal Health Incorporated gaining market shareEarnings Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Where is Elanco Animal Health Incorporated (ELAN) headed according to the Street? - MSN
DDD Partners LLC Decreases Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Douglas Lane & Associates LLC - MarketBeat
Elanco Animal Health Inc (STU:5EA) Bonds - GuruFocus
Elanco Animal Health Incorporat (ELAN) Stock forecasts - Yahoo Finance UK
Dimensional Fund Advisors (NYSE: ELAN) reports 24.5M shares beneficially owned - Stock Titan
Elanco Launches Advantage Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* - Finviz
Elanco Animal Health Inc (ELAN) Shares Gap Down to $22.82 on Apr 9 - GuruFocus
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* - PR Newswire
Elanco's new dog flea collar offers 4 months of coverage for under $25 - Stock Titan
Aug Sectors: Can Elanco Animal Health Incorporated expand its profit marginsLayoff News & Weekly Market Pulse Alerts - baoquankhu1.vn
Form DEF 14A Elanco Animal Health For: Dec 31 - StreetInsider
[DEF 14A] Elanco Animal Health Inc Definitive Proxy Statement - Stock Titan
BofA Securities Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Elanco (ELAN) executive awarded new deferred stock units under deferral plan - Stock Titan
Elanco (NYSE: ELAN) CEO awarded new deferred stock units as compensation - Stock Titan
Elanco (ELAN) CFO awarded new deferred stock units in Form 4 filing - Stock Titan
Elanco (ELAN) officer granted 40,985 shares, with 20,288 withheld for taxes - Stock Titan
Stifel reiterates buy on Elanco stock, keeps $32 price target - Investing.com
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
IVF In Animals Market Generated Opportunities, Future Scope - openPR.com
Veterinary Medication Market Set for Dynamic Boom as Key Players - openPR.com
Harbor Capital Advisors Inc. Sells 49,302 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
ELAN Technical Analysis & Stock Price Forecast - intellectia.ai
ELAN PE Ratio & Valuation, Is ELAN Overvalued - Intellectia AI
Maryland judge dismisses securities class action against Elanco over Zenrelia disclosures - DVM360
Elanco (ELAN) director defers fees into 600 Deferred Stock Units - Stock Titan
Elanco Animal Health Incorporated (ELAN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assessing Elanco Animal Health’s Valuation After Recent Share Price Swings And Product Launch Momentum - Yahoo Finance
Chewy reaches settlement in Elanco flea and tick antitrust litigation - DVM360
Elanco supports incubaFORUM ASIA 2026 as Premium-Platinum Sponsor - avinews.com
Decoquinate Market Is Going to Boom Rapidly With Top Key Players - openPR.com
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More - Yahoo Finance
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엘란코 주식 (ELAN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Modi Rajeev A. | SEE REMARKS |
Dec 11 '25 |
Buy |
21.33 |
4,500 |
95,985 |
123,082 |
| VanHimbergen Robert M | EVP and CFO |
Dec 11 '25 |
Buy |
21.64 |
6,950 |
150,426 |
124,233 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Dec 11 '25 |
Buy |
21.75 |
22,000 |
478,496 |
167,000 |
1.84%
6.22%
자본화:
|
볼륨(24시간):